BioCentury
ARTICLE | Financial News

Aug. 27 Financial Quick Takes: Prothena gains on EcoR1 investment; plus Pharmaron, Exagen

August 27, 2019 11:38 PM UTC

EcoR1 takes stake in Prothena
Prothena Corp. plc (NASDAQ:PRTA) jumped $1.87 (27%) to $8.93 Tuesday after it disclosed in an SEC filing Monday that EcoR1 Capital has acquired a 23.6% stake in the neurological disorder company for $63.5 million.

Pharmaron files for Hong Kong listing
Pharmaron Beijing Co. Ltd. (SZSE:300759) filed Monday to list on the Hong Kong stock exchange. The R&D service company went public on the Shenzhen stock exchange in January...